Doctors from Verve Therapeutics, a biotech company, injected a serum into monkeys with the abilities to shut off genes responsible for creating cholesterol and triglyceride fats. Heart disease and fatal heart attacks could be "cured" if this serum is created to accomplish the same in humans.
Researchers from the University of York are using laser-light technology to develop biosensors which could deliver real-time blood test results for patients with infections, to include COVID-19.
With face masks encouraged throughout the world, developers in Switzerland created HelloMasks, breathable, recycleable, and biodegratable masks made from organic biomass-based materials.
A laboratory at Boston University is infecting mini-lungs with COVID-19 to answer questions about why this virus kills infected individuals.
Machine learning, drug creation, and major diseases, how AI and biology could solve problems.
Research out of Boston University shows "Nanosponges" could act as a decoy and prevent the SARS-CoV-2 virus from taking hold of lung cells. This Research was supported by the Defense Threat Reduction Agency Joint Science and Technology office for Chemical and Biological Defense.
A recent study found 30% of all published papers since January 2020 on COVID-19 were authored by women. This study suggests gender biases seem to be affecting COVID-19 research similar to other scientific areas, highlighting that women are consistently being under-represented.
The new bio revolution will be knowledge gained from DNA sequencing and artificial intelligence to engineer organisms, such as curing incurable diseases or modifying crops to be more heat- or drought-resistant—traits that are ever more important given climate change.
A new study from chemical engineering researchers at the University of Arkansas made a leap forward in developing artificial kidneys. The researchers created a device that was able to filter blood in a way similar to biological nephrons.
A new study identified acompound, SCH-79797, that kills both Gram-negative and Gram-positive bacteria through a unique dual-targeting mechanism of action with undetectably low resistance frequencies. This study found the compound was effective against E. coli to MRSA.